Basta Steven L
SEC insider (Form 3/4/5 filer). CIK 0001417397. President and CEO at Phathom Pharmaceuticals, Inc. (PHAT) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Feb 10, 2026. Located in FLORHAM PARK.
Companies Basta Steven L has filed insider reports for
- Phathom Pharmaceuticals, Inc. (PHAT): Director, Officer, President and CEO
- VYNE Therapeutics Inc. (VYNE): Director
Basta Steven L
CIK: 0001417397
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Feb 10, 2026PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect12.4K shares- - Feb 10, 2026PHAT
Phathom Pharmaceuticals, Inc.
Tax PaymentDirect6.3K shares at avg. $12.82$80K - Jan 2, 2026PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect251K shares- - Dec 17, 2025PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect62K shares- - Dec 17, 2025PHAT
Phathom Pharmaceuticals, Inc.
Tax PaymentDirect31.5K shares at avg. $15.36$484K - Dec 12, 2025VYNE
VYNE Therapeutics Inc.
AwardDirectStock Option (right to buy)
20K shares- - Nov 28, 2025PHAT
Phathom Pharmaceuticals, Inc.
Tax PaymentDirect48.4K shares at avg. $15.62$756K - Nov 28, 2025PHAT
Phathom Pharmaceuticals, Inc.
ExerciseDirect90K shares- - Sep 25, 2025PHAT
Phathom Pharmaceuticals, Inc.
ExerciseDirect90K shares- - Sep 25, 2025PHAT
Phathom Pharmaceuticals, Inc.
Tax PaymentDirect48.4K shares at avg. $11.66$564K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 10, 2026 |  PHAT Phathom Pharmaceuticals, Inc. | Award | 12,362 | - | $0 | Direct |
| Feb 10, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Tax Payment | 6,277 | $12.82 | $80,471 | Direct |
| Jan 2, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Award | 251,034 | - | $0 | Direct |
| Dec 17, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award | 62,038 | - | - | Direct |
| Dec 17, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Tax Payment | 31,502 | $15.36 | $483,871 | Direct |
| Dec 12, 2025 |  VYNE VYNE Therapeutics Inc. | Award Stock Option (right to buy) | 20,000 | - | - | Direct |
| Nov 28, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Tax Payment | 48,375 | $15.62 | $755,618 | Direct |
| Nov 28, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Exercise | 90,000 | - | - | Direct |
| Sep 25, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Exercise | 90,000 | - | - | Direct |
| Sep 25, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Tax Payment | 48,375 | $11.66 | $564,053 | Direct |
1-10 of 13 transactions